On September 30, 2021, Activ Surgical, a digital surgery pioneer, announced that it has raised $45 million in a Series B financing round. The financing was led by Cota Capital and included participation from new investors, including BAM Funds, Magnetar Capital, MINT Venture Partners, Castor Ventures, Dream One Vision, and NVIDIA, as well as existing investors DNS Capital, Tao Capital Partners, LRVHealth, Rising Tide VC, GreatPoint Ventures (GPV), and ARTIS Ventures.

To date, Activ Surgical has raised a total of $77 million. Wilson Sonsini manages Activ Surgical’s patent matters, and supported IP due diligence in connection with the Series B financing and prior Series A round.

Activ Surgical is building a hardware-agnostic platform, including the recently announced ActivInsights™ augmented reality (AR)-based software suite, to enable autonomous and collaborative surgery through the integration of computer vision, artificial intelligence (AI), machine learning (ML), AR, and robotics.

The company will use the Series B financing round to support the commercial availability of the ActivInsights software suite, including the first Insight—an AR-based overlay that displays tissue perfusion in real time without the use of traditional dyes. Activ Surgical will also use the funds to support commercialization in the U.S., pursue a CE mark in support of the global rollout, and further enhance the ActivInsights software platform and develop its first ML-based insights.

The Wilson Sonsini team advising Activ Surgical on IP matters related to the financing includes Jim Heslin and Hin Au.

For more information, please see Activ Surgical’s press release.